Cogent Biosciences, Inc. (COGT)

37.34 -1.00 (-2.61%) USD  |  NASDAQ  |  Feb 20, 16:00
37.56 +0.22 (+0.59%) Pre-Market: 20:00
More

Cogent Biosciences Net Common Equity Issued (Purchased) (Quarterly)

Net Common Equity Issued (Purchased) (Quarterly) Chart

View Net Common Equity Issued (Purchased) (Quarterly) for COGT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Common Equity Issued (Purchased) (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Net Common Equity Issued (Purchased) (Quarterly) Range, Past 5 Years

View Net Common Equity Issued (Purchased) (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Common Equity Issued (Purchased) (Quarterly) Benchmarks

View Net Common Equity Issued (Purchased) (Quarterly) Benchmarks
Start Trial
Merck & Co., Inc. Upgrade
Sarepta Therapeutics, Inc. Upgrade
Cidara Therapeutics, Inc. Upgrade
BridgeBio Pharma, Inc. Upgrade
Olema Pharmaceuticals, Inc. Upgrade